Search for a clinical trial
Other search option(s)
7 Result(s)
Recruiting trial
= 
; Ongoing trial
= 
; Funded by an IRDiRC member = 
National clinical trial(s)
SPAIN
Cataluña
BARCELONA
FANCOSTEM-1: Clinical Phase II Trial to evaluate efficacy and safety of CD34+ cells mobilization and collection after treatment with plerixafor and filgrastim in patients with Fanconi anemia for subsequent transduction with a lentiviral vector carring FANCA gene and reinfusion in the patient - ES
Hospital Universitari Vall d'Hebron - Area Materno Infantil
Servicio de Oncología y Hematología Pediátricas
SPAIN
Cataluña
BARCELONA
Clinical Trial Phase I / II to evaluate the safety and efficacy of the infusion of autologous CD34+ cells transduced with a lentiviral vector carrying the FANCA gene (orphan drug) for patients with Fanconi Anemia Subtype A
Hospital Universitari Vall d'Hebron - Area Materno Infantil
Servicio de Oncología y Hematología Pediátricas
SPAIN
Madrid
MADRID
Clinical Trial Phase I / II to evaluate the safety and efficacy of the infusion of autologous CD34+ cells transduced with a lentiviral vector carrying the FANCA gene (orphan drug) for patients with Fanconi Anemia Subtype A
Hospital Infantil Universitario Niño Jesús
Servicio de Oncohematología
UNITED STATES
Ohio
CINCINNATI
Quercetin in Children With Fanconi Anemia; a Pilot Study (Phase 1) - US
Cincinnati Children's Hospital Medical Center
Department of Pediatry
GERMANY
Baden-Württemberg
ULM
EMAA: Efficacy and Safety of Eltrombopag in Patients with Acquired Moderate Aplastic Anemia who are treated with Ciclosporin A (Phase II/III) - DE
DRK Baden-Württemberg/ Hessen
Institut für Klinische Transfusionsmedizin und Immungenetik Ulm
SPAIN
Comunidad Valenciana
VALENCIA
RACE: A prospective Randomized multicenter study comparing horse Antithymocyte globuline (hATG) + Cyclosporine A (CsA) with or without Eltrombopag as front-line therapy for severe aplastic anemia patients (Phase III) - ES
Hospital Universitario y Politécnico La Fe
Servicio de Hematología y Hemoterapia
Multinational clinical trial(s)
SPAIN
Madrid
MADRID